close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

18.34 +0.73 (+4.18%)
Streaming Delayed Price Updated: 10:25 AM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Drug Development Inputs & Services Stocks Q2 In Review: Fortrea (NASDAQ:FTRE) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
News headline image
Fortrea (FTRE) Q2 2026 Earnings Call Transcript ↗
Biotech demand strengthens as backlog hits $7.8 billion and guidance rises. 
Via The Motley Fool
Topics Earnings
News headline image
Fortrea Q2 Earnings Call Highlights ↗
Fortrea (NASDAQ:FTRE) reported second-quarter 2026 revenue of $678.2 million and adjusted EBITDA of $58.7 million, while raising its full-year revenue and adjusted EBITDA outlook. Management said... 
Via MarketBeat
Topics Earnings
Fortrea Holdings (NASDAQ:FTRE) Jumps After Q2 Earnings Beat and Raised Full-Year Outlook ↗
Via Chartmill
Topics Earnings
Fortrea (NASDAQ:FTRE) Beats on Q1 Profit but Revenue Miss Caps Gains ↗
Via Chartmill
News headline image
Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full-Year Sales Guidance is Optimistic
Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2026 results exceeding the market’s revenue expectations, but sales fell by 4.5% year ... 
Via StockStory
News headline image
Fortrea Earnings: What To Look For From FTRE
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be announcing earnings results this Wednesday morning. Here’s what to look for. Fortrea beat an... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Sell FTRE and 1 Stock to Buy Instead
Fortrea trades at $17.93 and has moved in lockstep with the market. Its shares have returned 13.3% over the last six months while the S&P 500 has gained 11.4... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Overrated Stocks Walking a Fine Line
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab... 
Via StockStory
News headline image
1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
News headline image
Stocks making big moves yesterday: Fortrea, Kura Sushi, Energizer, Bath and Body Works, and Robinhood
Check out the companies making headlines yesterday: Fortrea (NASDAQ:FTRE): Clinical research company Fortrea Holdings (NASDAQ:FTRE) rose by 4.6% on Wednesday... 
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 4.6% in the morning session after Barclays raised its price target o... 
Via StockStory
Topics Earnings Initial Public Offering
News headline image
3 Cash-Producing Stocks with Warning Signs
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
3 Unpopular Stocks We’re Skeptical Of
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
News headline image
1 Unprofitable Stock to Research Further and 2 We Question
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
3 Overrated Stocks We Approach with Caution
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a... 
Via StockStory
News headline image
Spotting Winners: Fortrea (NASDAQ:FTRE) And Drug Development Inputs & Services Stocks In Q1
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind... 
Via StockStory
News headline image
Fortrea’s Q1 Earnings Call: Our Top 5 Analyst Questions
Fortrea’s first quarter results were well received by investors, as the company exceeded Wall Street expectations on both revenue and non-GAAP earnings. Mana... 
Via StockStory
Topics Earnings
News headline image
FTRE Q1 Deep Dive: Fortrea’s Commercial Momentum and Technology Focus Drive Margin Improvement
Clinical research company Fortrea Holdings (NASDAQ:FTRE) reported Q1 CY2026 results topping the market’s revenue expectations, but sales fell by 2.3% year on... 
Via StockStory
News headline image
Fortrea (FTRE) Shares Skyrocket, What You Need To Know
What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 20.3% in the morning session after it reported first-quarter 2026 re... 
Via StockStory
Topics Initial Public Offering
News headline image
Fortrea (FTRE) Q1 2026 Earnings Transcript ↗
Fortrea (FTRE) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Fortrea’s (NASDAQ:FTRE) Q1 CY2026 Sales Beat Estimates, Stock Soars
Clinical research company Fortrea Holdings (NASDAQ:FTRE) announced better-than-expected revenue in Q1 CY2026, but sales fell by 2.3% year on year to $636.5 m... 
Via StockStory
Topics Earnings
News headline image
Fortrea (FTRE) Q1 Earnings: What To Expect
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings this Tuesday before market open. Here’s what to look for. Fortrea missed ... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
News headline image
2 of Wall Street’s Favorite Stocks to Consider Right Now and 1 We Question
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Reasons to Avoid FTRE and 1 Stock to Buy Instead
Fortrea has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $9.39. Is there a buying opportunity in Fortr... 
Via StockStory
News headline image
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ... 
Via StockStory
News headline image
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci... 
Via StockStory
Topics Government Stocks
News headline image
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Government Stocks
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Turn Down
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have not only realized strong financial ... 
Via StockStory
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.